Business Description
Nektar Therapeutics is a San Francisco-based drug development company founded in 1990, focused on creating new treatments for autoimmune conditions, inflammatory diseases, cancer, and fibrosis. Its pipeline includes several promising drug candidates at various stages of clinical testing, with its lead program targeting immune system imbalances that drive autoimmune disorders. The company works alongside major pharmaceutical partners including Takeda, AstraZeneca, Pfizer, Bristol-Myers Squibb, and Roche, among others, to advance its research both in the United States and globally.
